A failed fragile X syndrome drug can reduce cocaine use, clinical trial finds
A team of pharmaceutical researchers at Novartis Biomedical Research, working with an international team of associates, has ...
FBLG: Phase 1/2 Trial in Diabetic Foot Ulcers to Initiate in 2Q25…
FBLG READ THE FULL FBLG RESEARCH REPORT Business Update Phase 1/2 Trial in Diabetic Foot Ulcers to Initiate in 2Q25 FibroBiologics, Inc. (NASDAQ:FBLG) is continuing preparations for a Phase 1/2 trial ...
Rolling Out4h
Sleep phases that could protect your brain from Alzheimer’s
Research reveals how specific sleep stages protect brain vulnerable to Alzheimer's, offering hope through simple lifestyle ...
NETRAMARK AND WORLDWIDE CLINICAL TRIALS ANNOUNCE AGREEMENT TO TRANSFORM CLINICAL TRIAL DESIGN WITH AI-POWERED PRECISION
CNW/ - NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier ...
Spending less time in 2 deep sleep stages may contribute to Alzheimer’s
Spending lower proportions of time in two deep sleep stages — including REM sleep — may be linked to volume changes in ...
The Manila Times11h
Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)
IHL-42X is designed to treat OSA by targeting its underlying pathophysiology. An oral fixed-dose combination of dronabinol and acetazolamide, IHL-42X is currently advancing through the RePOSA Phase ...
PharmiWeb13h
Cambridge Cognition selected for two Phase 3 trials combining digital cognitive and voice solutions
Cambridge Cognition (AIM: COG), the brain health software group specialising in digital products to advance clinical research and patient treatment, has been selected by a major pharmaceutical company ...
Clinical Trials Arena on MSN11h
Roche’s high-dose Ocrevus fails primary endpoint in MS trial
Higher doses of the company’s multiple sclerosis drug failed to show additional benefit in slowing rates of disability ...
Tourmaline Bio: We Should Wait For Upcoming Phase 2b Trial Data
Tourmaline Bio's Pacibekitug shows promise in IL-6 targeting for autoimmune diseases. Learn about its potential and ongoing trials. Read why TRML is a hold.
Advanced Cervical Cancer Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
In April 2025, Amgen announced a study is to evaluate the safety, tolerability, and to determine the maximum tolerated dose ...
The Edge Singapore16h
Li Ka Shing Foundation, Temasek Trust commit $12 mil to acquire systems, launch trials for histotripsy cancer therapy
The Histotripsy System generates microbubbles that rapidly expand and collapse, producing shock waves that break down tumours ...
T-Cell Acute Lymphoblastic Leukemia Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
In March 2025, Juventas Cell Therapy Ltd. conducted a phase Ib/II trial to evaluate the safety and efficacy of CNCT19 ...